Sleep and Morning Wellbeing Study

Exclusion Criteria

• •Diagnosed chronic sleep conditions (e.g., insomnia, narcolepsy, REM Behavior Disorder, moderate to severe restless leg syndrome, sleep apnea).
• •Current use of sleep-tracking technology (e.g., wrist-worn trackers, rings, smartphone apps) that could influence sleep behavior or perception.
• •Women currently undergoing perimenopause or experiencing vasomotor symptoms (e.g., night sweats).
• •Use of hormone therapy (estrogen, progesterone, phytoestrogens) within the last 3 months.
• •Diagnosed psychiatric disorders including major depressive disorder with acute symptoms, bipolar disorder, generalized anxiety disorder with active symptoms, and PTSD with frequent nightmares.
• •Diagnosed neurodegenerative or chronic pain disorders, including Parkinson's disease, Alzheimer's disease, or uncontrolled fibromyalgia.
• •Regular prescribed stimulant use (e.g., amphetamines such as Adderall/Vyvanse; methylphenidate such as Ritalin/Concerta; modafinil/armodafinil).
• •Current use of CNS-activating antidepressants (bupropion, fluoxetine, venlafaxine, sertraline).
• •Current or recent use of cannabis or THC-containing products (recreational or medicinal marijuana, CBD with measurable THC, synthetic cannabinoids) within the past 30 days.
• •Employment in jobs disrupting nighttime sleep (e.g., night shift, rotating shift, excessive travel).
• •Current use of prescription sleep aids.
• •Introduction of any new sleep-related supplements, medications, herbal remedies, or melatonin products during the study.
• •Use of any prescription or OTC products with sedative properties (e.g., melatonin, diphenhydramine, doxylamine, valerian, ZzzQuil, Advil PM) within 4 weeks prior to enrollment or habitual use ≥3 times per week prior to enrollment unless investigator-approved.
• •Allergy or sensitivity to any study product ingredients.
• •Pregnant, breastfeeding, or trying to conceive during the study period.
• •History of substance abuse.
• •Heavy alcohol use (≥8 drinks/week for women or ≥15 drinks/week for men).
• •Participation in another research study now or within the next 7 weeks.
• •Any condition or behavior that, in the investigator's judgment, may interfere with study participation or data integrity.